Cyclohexanecarbonitrile, 1-(2-ethylbutyl)-(855425-38-6)
- Name: Cyclohexanecarbonitrile, 1-(2-ethylbutyl)-
- Synonyms:Cyclohexanecarbonitrile, 1-(2-ethylbutyl)-
- Molecular Formula:C13H23N
- Molecular Weight:193.33
- CAS Registry Number:855425-38-6
- EINECS:619-573-9
- Melting Point:
- Water Solubility:
Other Product
- 1198178-65-2/Cyclopropanecarboxamide, 1-amino-N-(cyclopropylsulfonyl)-2-ethyl-, (1R,2R)-, 4-methylbenzenesulfonate (1:1)
- 123664-84-6/Methanesulfonamide, N-(5-methoxy-2-phenoxyphenyl)-
- 1001859-46-6/RiferMinogene PecaplasMid
- 665058-78-6/DNA, d(T-sp-C-G-sp-T-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-A-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-T-sp-C-G-sp-T-sp-T) (9CI)
- 923591-06-4/3H,5H-2,23:5,8-Dimethano-1H-4,13,2,8,11-benzodioxatriazacycloheneicosine-7-carboxylic acid, 10-(1,1-dimethylethyl)-6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-15,15-dimethyl-3,9,12-trioxo-, methyl ester, (5R,7S,10S)-
- 947408-94-8/1,2-Benzisoxazol-3(2H)-one, 6-methyl-2-(triphenylmethyl)-
- 947408-95-9/1,2-Benzisoxazol-3(2H)-one, 6-(bromomethyl)-2-(triphenylmethyl)-
- 913695-00-8/1H-Benzimidazole, 2-[[[4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethyl-2-pyridinyl]methyl]sulfinyl]-, sodium salt (1:1), (+)-
- 472960-22-8/Serum albumin (human) fusion protein with interferon α2 (human)
- 897936-89-9/Blood-coagulation factor VII [158-aspartic acid,296-valine,298-glutamine] (synthetic human)
- 158671-29-5/Benzamide, N,2-dihydroxy-4-methyl-
- 268544-50-9/2-[(2-Methoxy-2-oxoethoxy)imino]-3-oxobutanoic acid 1,1-dimethylethyl ester
- 855425-38-6/Cyclohexanecarbonitrile, 1-(2-ethylbutyl)-
- 579494-66-9/Benzeneacetic acid, 4-[2-(diethylamino)-2-oxoethoxy]-3-ethoxy-, propyl ester
- 610300-00-0/Octanoic acid, 3-amino-5-methyl-, hydrochloride (1:1), (3S,5R)-
- 702686-97-3/Benzenepropanoic acid, 3-[(2R)-3-[[2-(2,3-dihydro-1H-inden-2-yl)-1,1-dimethylethyl]amino]-2-hydroxypropoxy]-4,5-difluoro-, ethyl ester, hydrochloride (1:1)
- 945717-05-5/Benzeneethanamine, 4-chloro-3-ethyl-, hydrochloride (1:1)
- 503070-58-4/Benzeneacetic acid, α,α-diphenyl-, compd. with (α1R)-α1-[[[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexyl]amino]methyl]-4-hydroxy-1,3-benzenedimethanol (1:1)
- 1035455-90-3/2-Propanol, 1-(5-bromo-2,3-difluorophenoxy)-3-[[2-(2,3-dihydro-1H-inden-2-yl)-1,1-dimethylethyl]amino]-, hydrochloride (1:1), (2R)-
- 1034457-07-2/1H-Indene-2-ethanamine, 2,3-dihydro-α,α-dimethyl-, hydrochloride (1:1)
- 13054-81-4/4-CHLORO-3,5-HEPTANEDIONE
- 17752-16-8/Cholest-5-en-24-one, 3-hydroxy-, (3β)-
- 211515-46-7/Cyclohexanecarbonyl chloride, 1-(2-ethylbutyl)-
- 381209-09-2/1-(2-Ethylbutyl)cyclohexanecarboxylic acid
- 376608-74-1/Ethanol, 2-[[(3aR,4S,6R,6aS)-6-[[5-amino-6-chloro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-
- 499785-81-8/Pyrazinecarboxamide, 3,4-dihydro-3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)- (9CI)
- 519188-42-2/Propanoic acid, 3-(2-benzo[b]thien-5-ylethoxy)-
- 909110-25-4/β-Lymphotoxin receptor (human extracellular domain-containing fragment) fusion protein with immunoglobulin G1 (human γ1-chain Fc fragment)
- 879555-13-2/1-165-Erythropoietin (human JR-013), glycoform κ (9CI)
- 869858-13-9/Thrombin (synthetic human) (9CI)